This year, more than 1.5 million Americans will be diagnosed as having cancer.

There are many important decisions that they will need to make. The treatment they receive to combat their cancer is crucial, especially when response rates are low.

Standard or first-line treatments for cancer are unsuccessful on average at least 70% of times. When they fail, research shows that only 5 percent of patients with cancer respond to the second treatment plan.

A recent study published in the Journal of Clinical Oncology found that this is true. molecular profilingIt was used to guide the selection for cancer therapy. A drug that targets specific biomarkers of a cancer was found in 98 per cent of advanced cancer patients.

“With molecular profiling, a newly diagnosed cancer patient does not have to go down treatment paths that are not a good match or will not work for them,”Sandeep Reddy MD, an oncologist, is a clinical associate professor of Medicine at the Geffen/UCLA School of Medicine. “Molecular profiling also can help in the treatment of advanced cancers, when standard therapies have been exhausted and new treatment options are needed. Molecular profiling is truly transforming cancer care today.”

Dr. Reddy says that the earlier the right cancer treatment can be used, the more effective it is for the patient. Today, doctors like Reddy are able to make critical decisions using molecular tumour profiling technology called Caris Target Now. This allows them to treat cancer more effectively.

Caris Target Now molecular tumour profiling is used to identify the genetic and molecular characteristics of a cancerous tumor. It provides a list with possible options for cancer drugs that are likely to work. This includes some that might not be considered and others that may work better. It can also identify open clinical trials that may offer additional options based on the patient’s tumor biomarkers.

This personalized treatment for cancer can increase the quality of cancer patients’ lives and lower healthcare costs.

Ask your doctor for more information and to see if this technology is right for you.